Benzimidazolidinone derivatives as muscarinic agents
First Claim
Patent Images
1. A compound of Formula I or a pharmaceutically acceptable salt or prodrug thereof, whereinX is selected from the group consisting of C, O, N and S Z is selected from the group consisting of OH and N Y is selected from the group consisting of ═
- O, ═
N and ═
S or tautomers thereof;
SPU is a spacer unit providing a distance d between Z and N wherein —
SPU—
is a biradical selected from the group consisting of —
(CR6R7)n-A-, —
(CR6R7)p—
CH═
CH—
(CR6R7)q—
, and —
(CR6R7)p—
C≡
C(CR6R7)q—
wherein n, p, and q are each individually and independently in the range 0 to 5, such as 0, 1, 2, 3, 4, or 5 and A is absent or an optionally substituted —
C3-8-cycloalkyl;
N together with R1 and R2 form a heterocyclic ring wherein said heterocyclic ring is selected from the group consisting of and wherein the heterocyclic ring is substituted with one or more substituents R4 independently selected from the group consisting of hydrogen, halogen, hydroxy, C1-8-alkyl, C1-8-heteroalkyl, C3-8-cycloalkyl, C3-8-heterocyclyl, C5-10-aryl, C5-10-heteroaryl, C1-6-arylalkyl, C1-6-heteroarylalkyl, C1-8-alkoxy, O—
C2-8-alkenyl, O—
C2-8-alkynyl, S—
C1-8-alkyl, S—
C2-8-alkenyl, and S—
C2-8-alkynyl C1-8-alkylcarbonyl, C1-8-alkoxycarbonyl, C1-8-alkylidene, C2-8-alkenyl, C2-8-alkynyl, C1-6-alkyloxyimino, and C1-6-alkyloxyamino each of which may be optionally substituted with a substituent R5, wherein at least one R4 is not hydrogen, R5 is selected from the group consisting of hydrogen, halogen, hydroxy, C1-8-alkyl, C1-8-heteroalkyl, C1-8-alkoxy, C3-8-cycloalkyl, C3-8-heterocyclyl, C1-8-alkylcarbonyl, C1-8-alkylidene, C2-8-alkenyl and C2-8-alkynyl;
RX may be absent or selected from the group consisting of hydrogen, optionally substituted C1-8-alkyl, optionally substituted C3-8-cycloalkyl, optionally substituted C2-8-alkenyl, optionally substituted C2-8-alkynyl, CH2—
N(R5)(R5), CH2—
OR5, CH2—
SR5, CH2—
O—
C(═
O)R5, CH2—
O—
C(═
S)R5;
R3 may be present 0-4 times and selected from the group consisting of halogen, hydroxy, optionally substituted C1-8-alkyl, C1-8-alkoxy, optionally substituted C1-8-alkylidene, optionally substituted C2-8-alkenyl, optionally substituted, C2-8-alkynyl optionally substituted aryl, optionally substituted heteroaryl, optionally substituted C3-8-cycloalkyl, optionally substituted C3-8-heterocyclyl, and optionally substituted C1-8-alkylcarbonyl;
each R6 and each R7 is optionally and independently selected from the group consisting of hydrogen, halogen, hydroxy, optionally substituted C1-8-alkyl, optionally substituted C1-8-alkoxy, optionally substituted C1-8-heteroalkyl, optionally substituted C1-8-alkylidene, optionally substituted C2-8-alkenyl, optionally substituted C2-8-alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted C3-8-cycloalkyl, optionally substituted C3-8-heterocyclyl, optionally substituted C1-6-arylalkyl, optionally substituted C5-10-aryl, optionally substituted C1-8-alkylcarbonyl, optionally substituted —
C(O)NH-alkyl, optionally substituted —
C(O)NH-aryl, optionally substituted —
C(O)O-alkyl, optionally substituted —
C(O)O-aryl, optionally substituted —
OC(O)-alkyl, and optionally substituted —
OC(O)-aryl.
1 Assignment
0 Petitions
Accused Products
Abstract
Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.
-
Citations
21 Claims
-
1. A compound of Formula I
or a pharmaceutically acceptable salt or prodrug thereof, wherein X is selected from the group consisting of C, O, N and S Z is selected from the group consisting of OH and N Y is selected from the group consisting of ═ - O, ═
N and ═
S or tautomers thereof;
SPU is a spacer unit providing a distance d between Z and N wherein —
SPU—
is a biradical selected from the group consisting of —
(CR6R7)n-A-, —
(CR6R7)p—
CH═
CH—
(CR6R7)q—
, and —
(CR6R7)p—
C≡
C(CR6R7)q—wherein n, p, and q are each individually and independently in the range 0 to 5, such as 0, 1, 2, 3, 4, or 5 and A is absent or an optionally substituted —
C3-8-cycloalkyl;
N together with R1 and R2 form a heterocyclic ring wherein said heterocyclic ring is selected from the group consisting of and wherein the heterocyclic ring is substituted with one or more substituents R4 independently selected from the group consisting of hydrogen, halogen, hydroxy, C1-8-alkyl, C1-8-heteroalkyl, C3-8-cycloalkyl, C3-8-heterocyclyl, C5-10-aryl, C5-10-heteroaryl, C1-6-arylalkyl, C1-6-heteroarylalkyl, C1-8-alkoxy, O—
C2-8-alkenyl, O—
C2-8-alkynyl, S—
C1-8-alkyl, S—
C2-8-alkenyl, and S—
C2-8-alkynyl C1-8-alkylcarbonyl, C1-8-alkoxycarbonyl, C1-8-alkylidene, C2-8-alkenyl, C2-8-alkynyl, C1-6-alkyloxyimino, and C1-6-alkyloxyamino each of which may be optionally substituted with a substituent R5, wherein at least one R4 is not hydrogen,R5 is selected from the group consisting of hydrogen, halogen, hydroxy, C1-8-alkyl, C1-8-heteroalkyl, C1-8-alkoxy, C3-8-cycloalkyl, C3-8-heterocyclyl, C1-8-alkylcarbonyl, C1-8-alkylidene, C2-8-alkenyl and C2-8-alkynyl;
RX may be absent or selected from the group consisting of hydrogen, optionally substituted C1-8-alkyl, optionally substituted C3-8-cycloalkyl, optionally substituted C2-8-alkenyl, optionally substituted C2-8-alkynyl, CH2—
N(R5)(R5), CH2—
OR5, CH2—
SR5, CH2—
O—
C(═
O)R5, CH2—
O—
C(═
S)R5;
R3 may be present 0-4 times and selected from the group consisting of halogen, hydroxy, optionally substituted C1-8-alkyl, C1-8-alkoxy, optionally substituted C1-8-alkylidene, optionally substituted C2-8-alkenyl, optionally substituted, C2-8-alkynyl optionally substituted aryl, optionally substituted heteroaryl, optionally substituted C3-8-cycloalkyl, optionally substituted C3-8-heterocyclyl, and optionally substituted C1-8-alkylcarbonyl;
each R6 and each R7 is optionally and independently selected from the group consisting of hydrogen, halogen, hydroxy, optionally substituted C1-8-alkyl, optionally substituted C1-8-alkoxy, optionally substituted C1-8-heteroalkyl, optionally substituted C1-8-alkylidene, optionally substituted C2-8-alkenyl, optionally substituted C2-8-alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted C3-8-cycloalkyl, optionally substituted C3-8-heterocyclyl, optionally substituted C1-6-arylalkyl, optionally substituted C5-10-aryl, optionally substituted C1-8-alkylcarbonyl, optionally substituted —
C(O)NH-alkyl, optionally substituted —
C(O)NH-aryl, optionally substituted —
C(O)O-alkyl, optionally substituted —
C(O)O-aryl, optionally substituted —
OC(O)-alkyl, and optionally substituted —
OC(O)-aryl. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
- O, ═
Specification